These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2585781)

  • 21. [Therapy of the ocular form of Behçet disease with cyclosporin A].
    Pahlitzsch T; Wyrobisch W; Kämpe C; Wiederholt M
    Klin Monbl Augenheilkd; 1990 Jun; 196(6):466-9. PubMed ID: 2376943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.
    Masuda K; Nakajima A; Urayama A; Nakae K; Kogure M; Inaba G
    Lancet; 1989 May; 1(8647):1093-6. PubMed ID: 2566048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-alpha treatment of Behçet's disease.
    O'Duffy JD; Calamia K; Cohen S; Goronzy JJ; Herman D; Jorizzo J; Weyand C; Matteson E
    J Rheumatol; 1998 Oct; 25(10):1938-44. PubMed ID: 9779847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind trial of depot corticosteroids in Behçet's syndrome.
    Mat C; Yurdakul S; Uysal S; Gogus F; Ozyazgan Y; Uysal O; Fresko I; Yazici H
    Rheumatology (Oxford); 2006 Mar; 45(3):348-52. PubMed ID: 16263779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diffuse ulcerative lesions in the colon with intestinal Behçet's disease].
    Mori S; Tokutomi K; Kawamura H; Takeuchi A; Hashimoto T
    Ryumachi; 1989 Jun; 29(3):172-7. PubMed ID: 2814706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lymphocyte subsets in erythema nodosum-like skin lesions from patients with Behçet's disease].
    Yamana S; Jones L; Aoi K; Ishibe Y; Shimamoto T; Aoyama T
    Ryumachi; 1985 Nov; 25(5):344-7. PubMed ID: 3832477
    [No Abstract]   [Full Text] [Related]  

  • 27. Are erythema nodosum-like lesions and superficial thrombophlebitis prodromal in terms of visceral involvement in Behcet's disease?
    Coskun B; Oztürk P; Saral Y
    Int J Clin Pract; 2005 Jan; 59(1):69-71. PubMed ID: 15707468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Low dose cyclosporin treatment for ocular lesions of Behçet's disease].
    Kotake S; Ichiishi A; Kosaka S; Yoshikawa K; Minagawa R; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1290-4. PubMed ID: 1442355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission.
    Miller RA; Shen JY; Rea TH; Harnisch JP
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):441-9. PubMed ID: 3309088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte responses in juvenile chronic arthritis and Behçet's disease--cell number requirements and effects of glucocorticosteroid therapy.
    de Vere-Tyndall A; Knight S; Burman S; Denman AM; Ansell BM
    Clin Exp Immunol; 1982 Dec; 50(3):549-54. PubMed ID: 7165998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral prostaglandin E1 as a therapeutic modality for leg ulcers in Behçet's disease.
    Takeuchi A; Hashimoto T
    Int J Clin Pharmacol Res; 1987; 7(4):283-9. PubMed ID: 3596871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan.
    J Rheumatol; 1989 Apr; 16(4):506-11. PubMed ID: 2664172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Behçet's disease].
    Stokvis JC
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1585-6. PubMed ID: 3670445
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclosporin in Behçet's disease.
    Lancet; 1983 Aug; 2(8347):454-5. PubMed ID: 6135934
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapy of dermatologic disease with cyclosporin A.
    Brown MD; Gupta AK; Ellis CN; Rocher LL; Voorhees JJ
    Adv Dermatol; 1989; 4():3-27; discussion 28. PubMed ID: 2701795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome.
    Kiliç H; Zeytin HE; Korkmaz C; Mat C; Gül A; Coşan F; Dinç A; Simşek I; Süt N; Yazici H
    Rheumatology (Oxford); 2009 Nov; 48(11):1388-91. PubMed ID: 19717547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin A treatment of Behçet's disease: a long-term study.
    Díaz-Llopis M; Cervera M; Menezo JL
    Curr Eye Res; 1990; 9 Suppl():17-23. PubMed ID: 2384009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pheochromocytoma associated with Behçet's disease.
    Oishi S; Koga B; Sasaki M; Umeda T; Sato T
    Jpn J Clin Oncol; 1989 Sep; 19(3):283-6. PubMed ID: 2810825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.